Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3488)
All Articles published online
|
May 21, 2008 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Wang YC, Yu ZH, Liu C, Xu LZ, Yu W, Lu J, Zhu RM, Li GL, Xia XY, Wei XW, Ji HZ, Lu H, Gao Y, Gao WM, Chen LB. Detection of |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i19/3074.htm |
| Number | Citing Articles |
| 1 |
Marc Tänzer, Magdalena Liebl, Michael Quante. Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma. Pharmacology & Therapeutics 2013; 140(2): 133 doi: 10.1016/j.pharmthera.2013.06.005
|
| 2 |
Klara Cervena, Pavel Vodicka, Veronika Vymetalkova. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review. Mutation Research/Reviews in Mutation Research 2019; 781: 100 doi: 10.1016/j.mrrev.2019.05.002
|
| 3 |
Catherine A. Powell, Gabriella Villa, Trevor Holmes, Mahua Choudhury. Handbook of Famine, Starvation, and Nutrient Deprivation. 2019; : 1735 doi: 10.1007/978-3-319-55387-0_22
|
| 4 |
Evangelos Karamitrousis, Balgkouranidou I, Xenidis N, Amarantidis K, Biziota E, Koukaki T, Trypsianis G, Karayiannakis A, Bolanaki E, Lianidou E, Kakolyris S. Methylation status of RASSF1A associates with prognosis in metastatic gastric cancer. Gastroenterology & Hepatology: Open Access 2019; 10(6): 301 doi: 10.15406/ghoa.2019.10.00399
|
| 5 |
Shu-Huei Hsiao, Tim H.-M. Huang, Yu-Wei Leu. Excavating relics of DNA methylation changes during the development of neoplasia. Seminars in Cancer Biology 2009; 19(3): 198 doi: 10.1016/j.semcancer.2009.02.015
|
| 6 |
Xin Sun, Hao Li, Mingjun Sun, Yuan Yuan, Liping Sun.
Circulating Tumor DNA
RASSF1
Methylation for Predicting Cancer Risk: A Diagnostic Meta-Analysis
. Future Oncology 2019; 15(30): 3513 doi: 10.2217/fon-2019-0219
|
| 7 |
Yunqing Zeng, Huimin Rong, Jianwei Xu, Ruyue Cao, Shuhua Li, Yanjing Gao, Baoquan Cheng, Tao Zhou. DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.823905
|
| 8 |
Luis H T Sakamoto, Beatriz De Camargo, Mariana Cajaiba, Fernando A Soares, André L Vettore. MT1G Hypermethylation: A Potential Prognostic Marker for Hepatoblastoma. Pediatric Research 2010; 67(4): 387 doi: 10.1203/PDR.0b013e3181d01863
|
| 9 |
Vera Constâncio, Sandra P. Nunes, Catarina Moreira-Barbosa, Rui Freitas, Jorge Oliveira, Inês Pousa, Júlio Oliveira, Marta Soares, Carlos Gonçalves Dias, Teresa Dias, Luís Antunes, Rui Henrique, Carmen Jerónimo. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel. Clinical Epigenetics 2019; 11(1) doi: 10.1186/s13148-019-0779-x
|
| 10 |
Meysam Mosallaei, Goli Siri, Behrang Alani, Mehdi Shakouri Khomartash, Hamed Naghoosi, Farzad Pourghazi, Reza Heidari, Mehrdad N. Sabet, Javad Behroozi. Differential methylation of DNA promoter sequences in peripheral blood mononuclear cells as promising diagnostic biomarkers for colorectal cancer. Journal of Cancer Research and Therapeutics 2024; 20(3): 993 doi: 10.4103/jcrt.jcrt_2542_22
|
| 11 |
Abdel Hady Abdel Wahab, Hatem A. El-mezayen, Hayaat Sharad, Shaimaa Abdel Rahman. Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors. Tumor Biology 2011; 32(5): 845 doi: 10.1007/s13277-011-0156-7
|
| 12 |
Yunhe Gao, Kecheng Zhang, Hongqing Xi, Aizhen Cai, Xiaosong Wu, Jianxin Cui, Jiyang Li, Zhi Qiao, Bo Wei, Lin Chen. Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis. Oncotarget 2017; 8(4): 6330 doi: 10.18632/oncotarget.14064
|
| 13 |
Liang Min, Jinghua Chen, Meihong Yu, Deliang Liu. Using Circulating Tumor DNA as a Novel Biomarker to Screen and Diagnose Colorectal Cancer: A Meta-Analysis. Journal of Clinical Medicine 2023; 12(2): 408 doi: 10.3390/jcm12020408
|
| 14 |
Ranran Pan, Cong Zhou, Jie Dai, Xiuru Ying, Hang Yu, Jie Zhong, Yihan Zhang, Boyi Wu, Yiyi Mao, Dongping Wu, Jieer Ying, Wei Zhang, Shiwei Duan. Endothelial PAS domain protein 1 gene hypomethylation is associated with colorectal cancer in Han Chinese. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6856
|
| 15 |
Xiao-bing YE, You-wei ZHANG, Long-bang CHEN. Methylation status of DLEC1 promoter in colorectal cancer patients and its clinical relevance. Academic Journal of Second Military Medical University 2010; 30(8): 842 doi: 10.3724/SP.J.1008.2010.00842
|
| 16 |
Yuji Toiyama, Yoshinaga Okugawa, Ajay Goel. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer. Biochemical and Biophysical Research Communications 2014; 455(1-2): 43 doi: 10.1016/j.bbrc.2014.08.001
|
| 17 |
Enders K. O. Ng, Candy P. H. Leung, Vivian Y. Shin, Chris L. P. Wong, Edmond S. K. Ma, Hong Chuan Jin, Kent-Man Chu, Ava Kwong, Alfons Navarro. Quantitative Analysis and Diagnostic Significance of Methylated SLC19A3 DNA in the Plasma of Breast and Gastric Cancer Patients. PLoS ONE 2011; 6(7): e22233 doi: 10.1371/journal.pone.0022233
|
| 18 |
Yiping Qu, Siwen Dang, Peng Hou. Gene methylation in gastric cancer. Clinica Chimica Acta 2013; 424: 53 doi: 10.1016/j.cca.2013.05.002
|
| 19 |
Michel Neidhart. DNA Methylation and Complex Human Disease. 2016; : 9 doi: 10.1016/B978-0-12-420194-1.00002-6
|
| 20 |
Fei Hu, Li Chen, Ming-Yu Bi, Ling Zheng, Ji-Xiang He, Ying-Ze Huang, Yu Zhang, Xue-Lian Zhang, Qiang Guo, Ying Luo, Wen-Ru Tang, Miao-Miao Sheng. Potential of RASSF1A promoter methylation as a biomarker for colorectal cancer: Meta-analysis and TCGA analysis. Pathology - Research and Practice 2020; 216(8): 153009 doi: 10.1016/j.prp.2020.153009
|
| 21 |
Petra Hudler. Challenges of deciphering gastric cancer heterogeneity. World Journal of Gastroenterology 2015; 21(37): 10510-10527 doi: 10.3748/wjg.v21.i37.10510
|
| 22 |
Bingsheng Li, Aihua Gan, Xiaolong Chen, Xinying Wang, Weifeng He, Xiaohui Zhang, Renxiang Huang, Shuzhu Zhou, Xiaoxiao Song, Angao Xu, John Green. Diagnostic Performance of DNA Hypermethylation Markers in Peripheral Blood for the Detection of Colorectal Cancer: A Meta-Analysis and Systematic Review. PLOS ONE 2016; 11(5): e0155095 doi: 10.1371/journal.pone.0155095
|
| 23 |
Jennifer A Rusiecki, Maryam Al-Nabhani, Letizia Tarantini, Ligong Chen, Andrea Baccarelli, Mansour S Al-Moundhri. Global DNA Methylation and Tumor Suppressor Gene Promoter Methylation and Gastric Cancer Risk in an Omani Arab Population. Epigenomics 2011; 3(4): 417 doi: 10.2217/epi.11.65
|
| 24 |
Lasse Sommer Kristensen, Michael Raynor, Ida Candiloro, Alexander Dobrovic. Methylation profiling of normal individuals reveals mosaic promoter methylation of cancer-associated genes. Oncotarget 2012; 3(4): 450 doi: 10.18632/oncotarget.480
|
| 25 |
Haochang Hu, Cong Zhou, Bin Li, Yanfei Chen, Jie Dai, Yiyi Mao, Tianyi Huang, Hang Yu, Min Chen, Jun Zhao, Shiwei Duan. Diagnostic value of RASSF1A hypermethylation in colorectal cancer: a meta-analysis. Pathology - Research and Practice 2018; 214(10): 1572 doi: 10.1016/j.prp.2018.07.031
|
| 26 |
Yingjie Wang, Hongyu Liu, Mengsha Zhang, Jing Xu, Liuxian Zheng, Pengpeng Liu, Jingyao Chen, Hongyu Liu, Chong Chen. Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives. MedComm 2024; 5(9) doi: 10.1002/mco2.670
|
| 27 |
Yujun Li, Junrong Liang, Peng Hou. Hypermethylation in gastric cancer. Clinica Chimica Acta 2015; 448: 124 doi: 10.1016/j.cca.2015.07.001
|
| 28 |
Wan-Jiang Xue, Ying Feng, Fei Wang, Peng Li, Yi-Fei Liu, Yi-Bing Guo, Zhi-Wei Wang, Qin-Sheng Mao. The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer. Tumor Biology 2016; 37(8): 11249 doi: 10.1007/s13277-016-5001-6
|
| 29 |
CHANG LIU, NAN LI, HENG LU, ZHENGKAI WANG, CHUNYAN CHEN, LIN WU, JIONG LIU, YOUKE LU, FANGYU WANG. Circulating SFRP1 promoter methylation status in gastric adenocarcinoma and esophageal square cell carcinoma. Biomedical Reports 2015; 3(1): 123 doi: 10.3892/br.2014.388
|
| 30 |
Dong-Tao Shi, Mei Han, Nan Gao, Wenyan Tian, Weichang Chen. Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis. Tumor Biology 2014; 35(2): 943 doi: 10.1007/s13277-013-1123-2
|
| 31 |
Jennifer A Rusiecki, Ligong Chen, Vasantha Srikantan, Lei Zhang, Liying Yan, Matthew L Polin, Andrea Baccarelli. DNA Methylation in Repetitive Elements and Post-Traumatic Stress Disorder: A Case–Control Study of US Military Service Members. Epigenomics 2012; 4(1): 29 doi: 10.2217/epi.11.116
|
| 32 |
Nadia A. Mohamed, Eman M. Swify, Nabila F. Amin, Mona M. Soliman, Lubna M. Tag-Eldin, Nahla M. Elsherbiny. Is serum level of methylated RASSF1A valuable in diagnosing hepatocellular carcinoma in patients with chronic viral hepatitis C?. Arab Journal of Gastroenterology 2012; 13(3): 111 doi: 10.1016/j.ajg.2012.06.009
|
| 33 |
Jing Shi, Yi-Ping Qu, Peng Hou. Pathogenetic mechanisms in gastric cancer. World Journal of Gastroenterology 2014; 20(38): 13804-13819 doi: 10.3748/wjg.v20.i38.13804
|
| 34 |
Deng Zheng‐Hao, Wen Ji‐Fang, Xiao De‐Sheng, Zhou Jian‐Hua. Galectin‐1 is up‐regulated by RASSF1A gene in human gastric carcinoma cell line SGC7901. APMIS 2012; 120(7): 582 doi: 10.1111/j.1600-0463.2012.02874.x
|
| 35 |
Jun Nakamura, Tomokazu Tanaka, Yoshihiko Kitajima, Hirokazu Noshiro, Kohji Miyazaki. Methylation-mediated gene silencing as biomarkers of gastric cancer: A review. World Journal of Gastroenterology 2014; 20(34): 11991-12006 doi: 10.3748/wjg.v20.i34.11991
|
| 36 |
Enrique Quintero, Antonio Z. Gimeno-García, Eduardo Salido. Blood Tests for Early Detection of Colorectal Cancer. Current Colorectal Cancer Reports 2010; 6(1): 30 doi: 10.1007/s11888-009-0039-0
|
| 37 |
Nikola Kokanov, Milena Krajnovic, Snezana Cupic-Jovanovic, Bojana Kozik, Nina Petrovic, Ana Bozovic, Vesna Mandusic. RASSF1A and p16 promoter methylation and treatment response in chronic hepatitis C genotype 1b patients treated with pegylated interferon/ribavirin. Archives of Biological Sciences 2022; 74(1): 57 doi: 10.2298/ABS211208004K
|
| 38 |
Vera Constâncio, Sandra P. Nunes, Rui Henrique, Carmen Jerónimo. DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types. Cells 2020; 9(3): 624 doi: 10.3390/cells9030624
|
| 39 |
Ping-ping Wu, Ji-hong Zou, Ri-ning Tang, Yao Yao, Cheng-zhong You. Detection and clinical significance of DLC1 gene methylation in serum DNA from colorectal cancer patients. Chinese Journal of Cancer Research 2011; 23(4): 283 doi: 10.1007/s11670-011-0283-0
|
| 40 |
Ragaa H. Salama, Zain El-Abdeen A. Sayed, Ahmed M. Ashmawy, Wael A. Elsewify, Ghada M. Ezzat, Mahmoud A. Mahmoud, Aya A. Alsanory, Tasneem A. Alsanory. Interrelations of Apoptotic and Cellular Senescence Genes Methylation in Inflammatory Bowel Disease Subtypes and Colorectal Carcinoma in Egyptians Patients. Applied Biochemistry and Biotechnology 2019; 189(1): 330 doi: 10.1007/s12010-019-03017-x
|
| 41 |
Sepideh Shahkarami, Samaneh Zoghi, Nima Rezaei. Cancer Immunology. 2020; : 491 doi: 10.1007/978-3-030-30845-2_22
|
| 42 |
I. Balgkouranidou, D. Matthaios, A. Karayiannakis, H. Bolanaki, P. Michailidis, N. Xenidis, K. Amarantidis, L. Chelis, G. Trypsianis, E. Chatzaki, E.S. Lianidou, S. Kakolyris. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2015; 778: 46 doi: 10.1016/j.mrfmmm.2015.05.002
|
| 43 |
Gerda Egger, Matthias Wielscher, Walter Pulverer, Albert Kriegner, Andreas Weinhäusel. DNA methylation testing and marker validation using PCR: diagnostic applications. Expert Review of Molecular Diagnostics 2012; 12(1): 75 doi: 10.1586/erm.11.90
|
| 44 |
Jessica A. Howell, Shahid A. Khan, Susanne Knapp, Mark R. Thursz, Rohini Sharma. The clinical role of circulating free tumor DNA in gastrointestinal malignancy. Translational Research 2017; 183: 137 doi: 10.1016/j.trsl.2016.12.006
|
| 45 |
Nisha Padmanabhan, Toshikazu Ushijima, Patrick Tan. How to stomach an epigenetic insult: the gastric cancer epigenome. Nature Reviews Gastroenterology & Hepatology 2017; 14(8): 467 doi: 10.1038/nrgastro.2017.53
|
| 46 |
Charinya Pimson, Tipaya Ekalaksananan, Chamsai Pientong, Supannee Promthet, Nuntiput Putthanachote, Krittika Suwanrungruang, Surapon Wiangnon. Aberrant methylation ofPCDH10andRASSF1Agenes in blood samples for non-invasive diagnosis and prognostic assessment of gastric cancer. PeerJ 2016; 4: e2112 doi: 10.7717/peerj.2112
|
| 47 |
Sarah Kraus, Ajay Goel, Nadir Arber. Blood-based peptide, genetic, and epigenetic biomarkers for diagnosing gastrointestinal cancers. Expert Opinion on Medical Diagnostics 2010; 4(6): 459 doi: 10.1517/17530059.2010.532208
|
| 48 |
Lang Hu, Gang Chen, Hongping Yu, Xiaoqiang Qiu. Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma. Hepatology International 2010; 4(1): 423 doi: 10.1007/s12072-010-9164-8
|
| 49 |
Simon Ladefoged Rasmussen, Henrik Bygum Krarup, Kåre Gotschalck Sunesen, Martin Berg Johansen, Mogens Tornby Stender, Inge Søkilde Pedersen, Poul Henning Madsen, Ole Thorlacius-Ussing. The prognostic efficacy of cell-free DNA hypermethylation in colorectal cancer. Oncotarget 2018; 9(6): 7010 doi: 10.18632/oncotarget.24097
|
| 50 |
Neda Jabbara, Golnaz Asaadi Tehrani, Fatemeh Lalooha, Seyed Amir Farzam, Khadijeh Elmizadeh. Promoter Hypermethylation Analysis of the Tumor Suppressor Genes RASSF1A and RASSF2A in Iranian Endometrial Carcinoma Patients. International Journal of Cancer Management 2017; 10(4) doi: 10.5812/ijcm.8629
|
| 51 |
Eivor Alette Laugsand, Siv Sellæg Brenne, Frank Skorpen. DNA methylation markers detected in blood, stool, urine, and tissue in colorectal cancer: a systematic review of paired samples. International Journal of Colorectal Disease 2021; 36(2): 239 doi: 10.1007/s00384-020-03757-x
|
| 52 |
Triantafillos Liloglou, John K. Field. Epigenetics and Cancer, Part B. Advances in Genetics 2010; 71: 177 doi: 10.1016/B978-0-12-380864-6.00006-7
|
| 53 |
Evangelos I. Karamitrousis, Ioanna Balgkouranidou, Nikolaos Xenidis, Kyriakos Amarantidis, Eirini Biziota, Triantafyllia Koukaki, Grigorios Trypsianis, Anastasios Karayiannakis, Helen Bolanaki, George Kolios, Evi Lianidou, Stylianos Kakolyris. Prognostic Role of RASSF1A, SOX17 and Wif-1 Promoter Methylation Status in Cell-Free DNA of Advanced Gastric Cancer Patients. Technology in Cancer Research & Treatment 2021; 20 doi: 10.1177/1533033820973279
|
| 54 |
Keishi Yamashita, Shinichi Sakuramoto, Masahiko Watanabe. Genomic and epigenetic profiles of gastric cancer: Potential diagnostic and therapeutic applications. Surgery Today 2011; 41(1): 24 doi: 10.1007/s00595-010-4370-5
|
| 55 |
Xuchen Zhang, Helei Hou, Man Jiang, Xiaochun Zhang. Aberrant circulating tumor DNA methylation and exosomal microRNA biomarkers for early detection of colorectal cancer. Molecular Biology Reports 2023; 50(3): 2743 doi: 10.1007/s11033-022-08194-3
|
| 56 |
Haleh Akhavan-Niaki, Ali Akbar Samadani. DNA Methylation and Cancer Development: Molecular Mechanism. Cell Biochemistry and Biophysics 2013; 67(2): 501 doi: 10.1007/s12013-013-9555-2
|
| 57 |
Jinfeng Wen, Tuo Zheng, Kefeng Hu, Chunxia Zhu, Lihua Guo, Guoliang Ye. Promoter methylation of tumor-related genes as a potential biomarker using blood samples for gastric cancer detection. Oncotarget 2017; 8(44): 77783 doi: 10.18632/oncotarget.20782
|
| 58 |
Lian Li, Ji-Yeob Choi, Kyoung-Mu Lee, Hyuna Sung, Sue K. Park, Isao Oze, Kai-Feng Pan, Wei-Cheng You, Ying-Xuan Chen, Jing-Yuan Fang, Keitaro Matsuo, Woo Ho Kim, Yasuhito Yuasa, Daehee Kang. DNA Methylation in Peripheral Blood: A Potential Biomarker for Cancer Molecular Epidemiology. Journal of Epidemiology 2012; 22(5): 384 doi: 10.2188/jea.JE20120003
|
| 59 |
Ranran Pan, Hang Yu, Jie Dai, Cong Zhou, Xiuru Ying, Jie Zhong, Jun Zhao, Yihan Zhang, Boyi Wu, Yiyi Mao, Dongping Wu, Jieer Ying, Shiwei Duan. Significant association of PRMT6 hypomethylation with colorectal cancer. Journal of Clinical Laboratory Analysis 2018; 32(9) doi: 10.1002/jcla.22590
|
| 60 |
Carolina Oliveira Gigek, Elizabeth Suchi Chen, Danielle Queiroz Calcagno, Fernanda Wisnieski, Rommel Rodriguez Burbano, Marilia Arruda Cardoso Smith. Epigenetic Mechanisms in Gastric Cancer. Epigenomics 2012; 4(3): 279 doi: 10.2217/epi.12.22
|
| 61 |
Stefan David, Stephen J. Meltzer. Pre-Invasive Disease: Pathogenesis and Clinical Management. 2011; : 41 doi: 10.1007/978-1-4419-6694-0_4
|
| 62 |
S. L. Rasmussen, H. B. Krarup, K. G. Sunesen, I. S. Pedersen, P. H. Madsen, O. Thorlacius‐Ussing. Hypermethylated DNA as a biomarker for colorectal cancer: a systematic review. Colorectal Disease 2016; 18(6): 549 doi: 10.1111/codi.13336
|
| 63 |
Catherine A. Powell, Gabriella Villa, Trevor Holmes, Mahua Choudhury. Handbook of Famine, Starvation, and Nutrient Deprivation. 2018; : 1 doi: 10.1007/978-3-319-40007-5_22-1
|